To undertake a methodological review of statistical methods used in randomised controlled trials (RCTs) for handling intervention non-adherence.
Introduction
Randomised controlled trials (RCTs) and systematic reviews of RCTs provide the highest level of evidence for assessing the effects of healthcare interventions. 1 Researchers, however, still face challenges when undertaking RCTs. One of these is the nonadherence/non-compliance of trial participants to the intervention(s) protocol to which they are randomised.
Non-adherence has been shown to be associated with poorer patient outcomes, including higher mortality. 2 A meta-analysis across 569 trials estimated an average treatment non-adherence rate of 25%, 3 while another study reported the rate 23%. 4 
Current reporting guidelines for RCT (Consolidated Standards of Reporting Trials [CONSORT])
recommend the intention-to-treat (ITT) approach i.e. outcomes are compared according to original group allocation regardless of whether participants received the intervention according to the protocol or not. 5, 6 By doing so, ITT evaluates effectiveness of an intervention by mirroring the non-adherence to treatment that may occur in real-world practice. Whilst this may be true, it is argued that by ignoring non-adherence, ITT underestimates the 'true (or causal) effect' of the intervention because the analysis is diluted by non-compliers. [7] [8] [9] A commonly used approach by analysts to handling non-adherence is per protocol (PP) analysis where the outcomes of intervention are compared according to initial random allocation but excluding those participants who do not adhere to the intervention protocol. 10, 11 A systematic review of 100 RCTs identified 47% studies to have adopted some form of PP analysis. 12 The PP approach is prone to serious selection bias as it fails to preserve the original randomisation and causality of treatment effect cannot be claimed. 13 'As treated' (AT) analysis is another variant of non-ITT analysis, 14, 15 that classifies participants according to the intervention they receive regardless to their adherence to the trial protocol and like PP analysis is subject to selection bias. 16, 17 Several statistical methods have been developed for estimating causal treatment effects that take account of intervention non-adherence without introducing the biases inherent to PP or AT analyses. The statistical framework for causal inference in RCTs was M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT 5 | P a g e developed by Rubin, referred to as Rubin's Causal Model (RCM) where each participant is assumed to have a set of counterfactual outcomes. [18] [19] [20] [21] Under the RCM framework, several methods developed for handling non-adherence, including Instrumental Variable (IV) approach from the field of econometrics, 22 Complier Average Causal Effect (CACE) by Rubin, 14, 23 and Structural mean models (SMM) by Robins. 24 To our knowledge there has been no comprehensive review of the use of these statistical methods and their pros and cons.
We undertook a methodological review of RCTs that described statistical methods for handling non-adherence to intervention protocol. Given the bias associated with the methodology, we excluded studies that utilised PP analysis alone. The aims were to: (1) assess the range of statistical methods reviewed and applied in RCTs to handle nonadherence; (2) review the relative pros and cons of these statistical methods; (3) Make a pooled comparison of the treatment effects estimated by ITT and proposed statistical methods for handling non-adherence.
Methods
We conducted and reported this methodological review in accordance with the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) statement. 25 
Literature search strategy
We searched a number of bibliographic databases i.e. EMBASE (OvidSP), PsycInfo (OvidSP), MEDLINE (OvidSP), CINAHL (EBSCOHOST) and Cochrane Library for Methodological Studies (Wiley Online Cochrane Library) from inception to June 2015.
Database specific Boolean search strategies were developed using key terms i.e. 'intention to treat', 'as-treated', 'per protocol', 'non-adherence', 'complier average causal effect', 'CACE' (and synonyms). The reference lists of the included papers were manually checked.
Details of the search strategy are provided in the e-appendix (A).
Study selection
We included RCTs that reviewed statistical methods for handling non-adherence and applied these methods to actual/simulated trial participant data. Studies were excluded if: (1) they were available only as abstracts/titles and not as a full publication; (2) they adjusted for non-adherence but provided no information on the statistical basis of this method (this included studies that simply stated that they used 'IV' or 'CACE' analysis but gave no further M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT 6 | P a g e methodological details); 26 (3) they applied statistical methods for handling any potential confounding/bias but this was unrelated to non-adherence to intervention protocol. 27 
Data extraction
A database was compiled that captured information on characteristics of included studies, i.e. title, authors, journal, year of publication, population disease area, type of intervention, randomizing unit, study duration, type of outcomes, sample size and estimated treatment effect by ITT method and by the proposed methods. Detailed information was extracted on the method of statistical analysis applied i.e. name of the statistical method/framework, statistical estimators/algorithm applied to implement the technique and any advantages/disadvantages of these statistical method as stated by authors.
Data analysis and presentation
A descriptive approach was taken to data presentation using frequencies, means and medians. Pooled comparison of direct treatment effects across studies was not feasible as studies had varied outcomes. For comparison of treatment effect between ITT and the proposed methods, we compared whether the treatment effect by ITT was larger or smaller compared to the effect estimated by the proposed method (coded 'yes/no') and presented the results in frequency (%). Further, absolute z-statistic [(treatment effect / standard error (s.e.)] was calculated for each method application and the pooled mean z-statistic was compared between ITT and proposed methods. This pooled comparison accounted for within-study variance by subtracting each proposed method z-statistic from ITT-z-statistic before calculating pooled mean z-statistic i.e. ∑ [(Z p -Z ITT ) / n], where Z is the z-statistic for proposed (p) or ITT method and n is the number of applications. The pooled z-statistic was also used to compare treatment effect between IV vs CACE method by meta-regression accounting for non-adherence rate. Applications made on simulated data and applications involving Bayesian method were excluded from these comparisons. Authors presented information in various formats i.e. presenting coefficient and 95% confidence interval (CI), presenting coefficient and s.e or presenting coefficient and the P-value only. We derived required statistic applying appropriate formulae, [28] [29] [30] 
Selection of included RCTs
The literature searches resulted in a total of 4,664 titles/abstracts, of which 58 were eligible for inclusion ( Figure 1 ). A total of 2,591 (56%) of the abstracts were excluded because authors exclusively relied on PP analysis to deal non-adherence. A small number of studies were also excluded for applying AT analysis (26 studies, 0.56%) and modified ITT (84 studies, 1.8%) as both are forms of PP analysis. 12 The other reasons for exclusions were applications that were non-RCTs, unrelated to handling non-adherence or lacked methodological details. 
Figure 1: Flow of studies through inclusion and exclusion process

Characteristics of included RCTs
Detailed description of included studies is given in the e-Appendix (B). Summary of study characteristics is presented in Table-1 . Majority of included studies were published in statistical/methodological journals. Studies were undertaken across a wide range of patient and intervention types, study sizes, duration and were applied across a range of outcome types (continuous/binary/count/time-to-event).
Characteristics
Number Percent (%)
Number of articles 58 100
Year of publication (n = 58) 
Statistical methods and estimators used in included RCTs to handle nonadherence
A total of nine methods for handling treatment non-adherence were described across the included studies (Table 2a) . Some of these studies applied more than one method using different estimators resulting in a total of 88 statistical method applications. Studies that were judged to be variants of a common statistical approach were grouped under broader approach i. 23 and 'IV-estimator' refers to implementation of a particular method applying two-stage least square (2SLS) estimator. 32 A total of 10 estimators (Table   2b) ML base estimators were implemented with Expectation Maximization (EM) algorithm, 33 and Bayesian Inference (BI) base methods were implemented both with EM and Markov-Chain
Monte-Carlo (MCMC) algorithm. 34 As shown in Figure 2 
Pros and cons of statistical methods presented by authors
The remainder of the methods section and Table 3 provide an overview of the statistical basis of the statistical methods and stated pros and cons of these approaches.
Complier Average Causal Effect (CACE)
Based on counterfactual outcome, 21 the CACE method was introduced by Angrist et al. for estimating causal effects in the presence of non-adherence. 23 In CACE analysis the potential adherence classes are stratified into four principal strata based on principal stratification, 35 i.e. always receive the treatment regardless of randomisation and iv) 'Defiers' i.e. always do the opposite of what is assigned and assumed to be non-existent. In addition to randomisation and the stable unit treatment value assumption (SUTVA), 36, 37 there are two key assumptions that need to be fulfilled for CACE model to be identified: (1) the effect of treatment assignment on outcomes entirely operates through treatment receipt status of participants, known as "exclusion restriction" (ER). ER in other words states that under true randomization, the proportion of non-compliers in the control group (had they been offered the treatment) and their outcomes are similar to the proportion of observed non-compliers and their outcomes in the treatment group; (2) The "monotonicity" assumption implies that there are no 'defiers' meaning no participants will refuse treatment when assigned to treatment and will seek treatment when assigned to control. Though the initial CACE estimator proposed by Angrist et al. was an IV estimator, 23 we identified several other estimators for CACE applied into different settings (Figure 2a ). Our findings, across several types of CACE applications, suggest that ML-base estimation was applied more often than other estimators and the reason may be that ML estimates are considered more efficient than 2SLS (Two-Stage Least Square) based IV estimators. [38] [39] [40] We also found applications of IV estimators in combination with ML estimators in estimating CACE and this combination contributed to substantial methodological development. 41 Missing data adds another level of complexity in presence of treatment non-adherence and in over half of CACE applications (24/47) authors provided guidelines for handling missing data. CACE also has been implemented in cluster randomised trials where intra-class correlation (ICC) from similar adherence behaviour at cluster level may compromise estimated treatment effects. [42] [43] [44] [45] When there are multiple arms involved, CACE model may suffer from non-identifiability issues or may require complex modelling assumptions, 46, 47 and Bayesian methods may be applied addressing such complexities. 48 The fundamental limitation of the CACE approach is that the underlying assumptions i.e. ER, monotonicity are not easily testable, [49] [50] [51] [52] and if violated CACE estimates may be biased. 41, 52, 53 
Instrumental variable (IV)
An IV is an exogenous variable that influences the outcome solely through a binary post-treatment variable that identifies whether participants adhered to treatment or not. 21, 22 Typically in RCTs, an IV is the randomizing variable and participants' adherence status is the endogenous variable through which outcome is affected. The assumption that outcome solely depends on adherence status is equivalent to the ER assumption discussed in the CACE section above. Therefore, in a two-arm trial design where participants' choice to postrandomisation switching between arms is restricted, an IV estimates alternate CACE
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We found IV methods, like CACE, being applied in varied scenarios. However, IV with 2SLS is likely to estimate treatment effect on complete case basis and valid only when missing data are ignorable. 32 When compliance rate is low, 2SLS-base IV estimator produces large effects compared to ITT and produces large variances which makes it a less attractive estimator. 55 In such scenarios, ML is a more efficient estimator of IV. 56 A variation of IV method is Adjusted Treatment Received (ATR) method introduced by Nagelkerke 57 with an adjustment made to error terms. The distinction to typical IV method is that in ATR, the error terms from first stage endogenous regression is added to the model as a covariate to allow adjustment for any unmeasured confounding.
Other statistical methods
Structural Mean Model (SMM)/Structural Nested Mean Model (SNMM) was
introduced by Robins. 24 The framework provides causal treatment effect for observed adherence comparing with a conditional reference level of adherence. 47 Linear additive framework is used for continuous outcomes and multiplicative framework is used for binary outcomes. Models are estimated with the G-estimator (GE) proposed by Robins and Tsiatis. 58, 59 The appealing aspect of SMM is that causal parameters can be estimated for varying levels of adherence. However identifying reference level of compliance may be challenging. 60 Another version of SMM applied to accelerated failure time (AFT) model (time to event survival data with time as outcome) is Rank Preservative Structural Failure Time model (RPSFTM). 61, 62 They are called rank preserving because they use a class of rank estimators for subjects' failure. 62 In practice, G-estimators have not been widely adopted due to level of complexities involved in implementation. 63 For handling non-adherence in continuous time survival data include Cox-reg (1, 2) , Complier proportional hazard effect of treatment (C-PROPHET) model and Causal accelerated life model (CALM). 64, 65 Cox-reg (1, 2) both are adherence adjustment base Cox-regression implemented by Cox-PH estimator. i) With binary outcomes, in some instances with complex study design i.e. three arms, the estimating equation has no solution. ii) G-estimation can be complex in implementation.
ATR
IV
Variation of IV method with error term from endogenous regression added in the model as covariate i) Method copes with missing data problems as the first stage uses all randomized participants.
Only the second stage is affected with missing data i) Method only valid when patients switch between treatment arms, for example when one arm consists of placebo therapy and a placebo effect is not anticipated.
RPSFTM
3 GE Estimates parameters of a class of semi-parametric failure time models, using a class of rank estimators. These models are the structural version of the "accelerated failure time model with time-dependent covariates" i) Yields valid results for both outcome-dependent and outcome-independent treatment non-compliance ii) designed to consistently estimate causal effects on the treated, without direct assumptions about the compliance selection mechanism i) RPSFTM makes a strong noninteraction assumption which in certain settings might be considered biologically implausible ii) G-estimation can be complex in implementation. 
C-PROPHET
Comparison of estimated treatment effects
We were able to compare treatment effect for 68/88 applications. The majority of the alternative methods (n = 48, 71%) produced treatment effects that were greater than the treatment effect estimated by ITT. For 11 applications (16%) estimates were similar for both ITT and the proposed methods. For all alternative methods, excluding the Bayesian applications, 95% CIs overlapped with the CIs of ITT either at lower or upper bound region.
64/88 applications contributed to the calculation of standard errors and z-statistics. In 83% of the applications (53/64), standard errors for the alternative methods were larger than the s.e. of ITT estimates. After accounting for within study variation, average z-statistic from proposed methods were greater by +0.13 SD (95% CI: -0.99 to 1.71). We found 7 out of 58 studies (12%) achieved significant treatment effect by applying an alternative method which was not achieved by the ITT method.
In meta-regression, when accounted for percent non-adherence rate, z-statistic for IV method was no different than z-statistic from ITT (-0.01, 95% CI: -0.27 ti 0.26) but z-statistic from CACE were greater by +0.18 SD (0.18, 95% CI: -0.01 to 0.35). CACE estimates were higher by the same amount when compared to IV.
Discussion
In this review, across 58 studies, a wide variety of statistical methods against ITT were identified for handling treatment non-adherence. The median intervention nonadherence was 38% ranging across studies from 2% to 78%. The two most commonly used methods were Complier Average Causal Effect (CACE) and Instrumental Variable (IV).
Overall, there was no significant difference between the pooled z-statistics from ITT and the alternative methods. In general, the majority of the proposed applications (83%) produced larger error variance compared to the error variance produced by ITT. We note that use of the CACE method resulted in larger z-statistics compared to the IV method when accounting for non-adherence rate.
We are aware of two previous systematic reviews undertaken to assess the analytical approaches to the handling of treatment protocol non-adherence in RCTs. Dodd et al. 12 summarised the extent to which non-adherence to treatment protocol is reported in RCTs. However, this study did not identify methods apart from the conventional ITT, PP and reported that 63% of the studies adopted ITT, 21% PP and 3% AT analysis. Our systematic review is therefore the first to identify and systematically reviewed statistical methods that have been developed to handle non-adherence using a causal inference framework.
The CACE and IV methods are flexible and have been applied across a range of RCT designs. One of the benefits of the CACE application is that cell-specific treatment effect can be obtained which can provide valuable insights for researchers in relation to various types of adherence, whereas this opportunity is limited for the IV approach. We also found good number of applications of MOM estimators (19/88, 22% applications), but we avoided emphasizing on it as it relies on simple cell means and ignores distributional error terms which can be erroneous. 52, 67 According to our findings, both CACE and IV methods are applicable to varieties of scenarios and both rely on strong assumptions that are vulnerable to violations. Unless there are direct ways of testing the assumptions, it is not readily verifiable whether the applied methods captured the true treatment effect or simply inflated the treatment effect influenced by level of adherence.
Strengths and limitations
The strength of this study was its use of a systematic review approach to identify studies for inclusion. However, it has a number of limitations. Study selection and data extraction was undertaken by a single reviewer (MM) although the opinion of a second reviewer (RST) was available. We were unable to compare treatment effects estimated by different statistical methods because of their varied outcomes. The comparison of pooled zstatistic may not be an ideal approach, but this provides an indication of location of treatment effect estimated by different methods around the region of significance. We excluded studies that implemented relevant methods purely for application purposes instead of providing methodological guidance for handling sub-optimal adherence and also studies that used statistical methods for handling general confounding other than handling non-adherence exclusively e.g. propensity score (PS), inverse probability weighting (IPW). These methods have wider applications in observational studies for adjusting general confounding based on probabilistic weighting, but they directly do not contribute to the formation of causal frameworks for handling non-adherence.
Implications for practice and policy
Usually the ITT estimate of a treatment effect will be smaller than the 'true' effect since if the treatment works, non-compliance to treatment means suboptimal effects.
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Conclusions
Our review found that the alternative methods for handling non-adherence rely on strong assumptions that may be vulnerable to violations. More empirical studies are needed that directly compare the usability and performance of different statistical methods for nonadherence in RCTs. 
What is already known
Randomised controls trials (RCTs) often suffer from non-adherence or noncompliance of trial participants to the intervention(s) protocol to which they are randomised.
Per-protocol (PP) and as-Treated (AT) are two naïve analytical methods for handling non-adherence in RCTs, which are prone to serious selection bias and cannot claim causal treatment effect.
Several statistical applications based on causal inference are now available to more appropriately adjust treatment effect for non-adherence in RCTs data.
What this study adds
Our methodological review shows that, a large proportion of RCTs continue to rely on naïve PP method for handling intervention non-adherence.
Maximum likelihood (ML) based Complier Average Causal Effect (CACE) and
Instrumental Variable (IV) methods are applied in various settings to handle nonadherence in RCTs.
